osteoarthritis
While these differences may represent differential behaviour of synovial fibroblasts in in vitro culture, these observations suggest that TFPI2, GRObeta (CXCL2), MnSOD and GCP-2 (CXCL6) may represent new targets for treatments specifically tailored to osteoarthritis.
While these differences may represent differential behaviour of synovial fibroblasts in in vitro culture, these observations suggest that TFPI2, GRObeta (<span class="gene" id="15292528-12-154-159">CXCL2</span>), MnSOD and GCP-2 (CXCL6) may represent new targets for treatments specifically tailored to <span class="disease" id="15292528-12-252-266">osteoarthritis</span>.